期刊文献+

CXCR2在胰腺导管细胞癌中的表达及意义 被引量:2

Significance and expression of CXCR2 in pancreatic ductal adenocarcinoma
下载PDF
导出
摘要 目的:探讨CXC趋化因子受体2(CXCR2)在胰腺导管细胞癌中的表达以及与其发生、发展的关系。方法:采用RT-PCR法、Western blot免疫印迹法检测50例胰腺导管细胞癌组织及癌旁组织和30例正常胰腺组织中CXCR2的表达水平,分析其与胰腺导管细胞癌生物学特性的关系。结果:胰腺导管细胞癌组织、癌旁组织和正常胰腺组织中CXCR2 mRNA和蛋白的表达分别为1.13±0.25、0.79±0.18、0.78±0.14和1.75±0.21、1.01±0.15、0.96±0.20,同癌旁组织和正常胰腺组织比较,胰腺导管细胞腺癌组织中CXCR2 mRNA和蛋白的表达明显升高(P<0.05)。同正常胰腺组织相比,癌旁组织中CXCR2mRNA和蛋白表达无明显升高(P>0.05)。CXCR2 mRNA和蛋白表达与肿瘤分化程度、淋巴转移和TMN分期密切相关,差异有统计学意义(P<0.05)。结论:CXCR2在胰腺导管细胞癌中高表达,与胰腺导管细胞癌发生、迁移、侵袭和转移等恶性生物学行为相关。 Objective: To examine the expression of CXC chemokine receptor 2 (CXCR2) in pancreatic dutal adenocarcinoma, and determine its role in tumorigenesis and progression of pan- creatic dutal adenocarcinoma. Methods- CXCR2 mRNA and protein expression in 50 specimens of pancreatic dutal adenocarcinoma, and adjacent pancreatic tissues, 30 of normal pancreatic tissues was examined by using semi-quantitative reverse transcription-PCR and Western blot. Results:The expression levels of CXCR2 mRNA and protein in pancreatic dutal adenocarcinoma, adjacent pan- creatic tissues and normal pancreatic tissues were 1.13 + 0.25,0.79 + 0.18 and 0.78 + 0.14 and 1.75 + 0.21, 1.01 + 0.15 and 0.96 + 0.20 respectively. As compared with adjacent pancreatic tissues and normal pancreatic tissues, the expression levels of CXCR2 mRNA and protein in pancreatic dutal adenocarci- noma were significantly increased(P〈0.05). No significant difference in the expression levels of CXCR2 mRNA and protein between adjacent pancreatic tissues and normal pancreatic tissues (P〉0.05). The expression levels of CXCR2 mRNA and protein were relevant to the degree of tumor differentitation, lymphatic metastasis and TMN staging with the difference being significant(P〈O.05). Conclusion: CXCR2 was highly expressed in pancreatic dutal adenocarcinoma. CXCR2 might play a role in the tu- morigenesis, migration, invasion and metastasis of pancreatic dutal adenocarcinoma.
出处 《中国现代普通外科进展》 CAS 2014年第2期123-126,共4页 Chinese Journal of Current Advances in General Surgery
关键词 胰腺导管细胞癌 趋化因子 CXCR2 Pancreatic dutal adenocarcinoma.ChemokineoCXC chemokine repector 2
  • 相关文献

参考文献12

  • 1Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angingenesis [J]. J Biol Chem, 1995.270(45):27348-27357.
  • 2Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Methnd[J]. Methods, 2001,25(4):402-408.
  • 3Green AR. Green VL, While MC, et al. Expression of cytokine mes- senger RNA in normal and neoplastic human breast tissue: identifi- cation of interleukin-8 as a potential regulatory factor in breast tu- mours[J]. Int J Cancer, 1997,72(6):937-941.
  • 4Ferrer FA, Miller I J, Andrawis RI, et al. Angiogenesis amt prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells[J]. Urology, 1998,51 ( 1 ): 161 - 167.
  • 5Kitadai Y, Haruma K, Sumii K, et al. Expression?of interleukin-8 correlates with vascularity in human gastric carcinomas [J]. Am J Pathol, 1998,152(1):93-100.
  • 6Brew R, Southern SA, Flanagan BF, et al. Detection of interleukin- 8 mRNA and protein in human colorectal carcinoma cells [J]. Eur J Cancer, 1996,32A(12):2142-2147.
  • 7Colasante A, Mascetra N, Brunetti M, et al. Transforming growth factor b1, interleukin-8 and interleukin-1 in non-small cell lung cancer[J]. Am J Respir Crit Care Med, 1997, 156:968-973.
  • 8Singh RK, Varney MI,. Regulation of?interleukin 8?expression in human malignant melanoma cells[J]. Cancer Res, 1998.58(7):1532- 2537.
  • 9Galffy G, Mohammed KA, Dowling PA, et al. Interleukin 8: an au- toerine growth factor for malignant mesothelioma [J]. Cancer Res, 1999,59(2):367-371.
  • 10Dhawan P, Richmond A. Role of CXCL1 melanoma[J]. J Leukoc Biol, 2002,72(1):9-18.

同被引文献20

  • 1Werner J, Combs SE, Springfeld C, et al. Advanced-stage pancreatic cancer: therapy options [ J]. Nat Rev Clin Oncol, 2013, 10: 323-333.
  • 2Reznik R, Hendifar AE, Tuli R. Genetic determinants and potential therapeutic targets for pancreatic adenoeareinoma [ J ]. Front Physiol, 2014,5 : 87.
  • 3Lonardo E, Frias-Aldeguer J, Hermann PC, et al. Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness[J]. Cell Cycle, 2012, 11: 1282- 1290.
  • 4Hertzer KM, Donald GW, Hines OJ. CXCR2: a target for pancreatic cancer treatment [ J] ? Expert Opin Ther Targets, 2013, 17 : 667-680.
  • 5Wang S, Wu Y, Hou Y, et al. CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth [J]. Transl Oncol, 2013, 6: 216-225.
  • 6Huang J, Zhang J, Li H, et al. VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer[J]. Am J Transl Res, 2013, 5: 336-346.
  • 7Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor [ J ]. Science, 1991, 253 : 1280-1283.
  • 8Singh S, Singh AP, Sharma B, et al. CXCL8 and its cognate receptors in melanoma progression and metastasis [ J ]. Future Oncol, 2010, 6: 111-116.
  • 9Ohri CM, Shikotra A, Green RH, et al. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer[J]. BMC Cancer, 2010, 10: 172.
  • 10Snoussi K, Mahfondb W, Bouaouina N, et al. Combined effects of IL-8 and CXCP,2 gene polymorphisms on breast cancer susceptibility and aggressiveness [ J]. BMC Cancer, 2010, 10: 283.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部